N. Yu, K. R. Tucker, E. S. Levitan, P. D. Shepard, C. C. Canavier: Implications of cellular models of dopamine neurons for schizophrenia. In: Progress in molecular biology and translational science. Band 123, 2014, S. 53–82, doi:10.1016/B978-0-12-397897-4.00011-5, PMID 24560140, PMC 4351765 (freier Volltext) (Review).
nbn-resolving.de
Erik Kwidzinski: Beteiligung der Indolamin 2, 3-Dioxygenase (IDO) an Immunregulation des zentralen Nervensystems. Dissertation, Charité Berlin, 13. Februar 2006, urn:nbn:de:kobv:11-10059777
nih.gov
ncbi.nlm.nih.gov
M. Fischer u. a. In: Br. J. Psychiatry, 115 (1969), S. 981–990, PMID 5387002
S. Onstad u. a. In: Acta Psychiatr. Scand., 83 (1991), S. 395–401, PMID 1853734
Seymour S. Kety u. a.: Mental illness in the biological and adoptive relatives of schizophrenic adoptees. Replication of the Copenhagen Study in the rest of Denmark. In: Arch Gen Psychiatry 51 (1994), S. 442–455, PMID 8192547
I. I. Gottesman, A. Shields: A critical review of recent adoption, twin and family studies of schizophrenia: behavioral genetics perspectives. In: Schizophrenia Bulletin, 2(1976), S. 360–401, PMID 1034336.
C. M. Lewis u. a.: Genom-scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. In: American Journal of human genetics, 2003, 73, 1, S. 34–48, PMID 12802786.
G. Kirov u. a.: Finding Schizophrenia Genes. In: J. Clini. Invest., 2005 115 (6), S. 1440–1448, PMID 15931379.
A. S. Bassett: Chromosomal aberrations and schizophrenia. Autosomes. In: British Journal of Psychiatry, 161 (1992), S. 323–334, PMID 1393302.
G. Silberberg, A. Darvasi, R. Pinkas-Kramarski, R. Navon: The involvement of ErbB4 with schizophrenia: association and expression studies. In: Am J Med Genet B Neuropsychiatr Genet., 2006 Mar 5; 141(2), S. 142–148, PMID 16402353
D. R. Weinberger: Genetic mechanisms of psychosis: in vivo and postmortem genomics. In: Clin Ther., 2005; 27 Suppl A: S8 – 15, PMID 16198200
N. Norton, H. J. Williams, M. J. Owen: An update on the genetics of schizophrenia. In: Curr Opin Psychiatry, 2006 Mar; 19(2), S. 158–164, PMID 16612196
George Kirov, Michael C. O’Donovan, Michael J. Owen: Finding schizophrenia genes. In: J Clin Invest., 2005 June 1; 115(6), S. 1440–1448, PMID 15931379
M. J. Owen, N. Craddock, M. C. O’Donovan: Schizophrenia: genes at last? In: Trends Genet. 2005 Sep; 21(9), S. 518–525, PMID 16009449
P. J. Harrison, D. R. Weinberger: Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. In: Mol Psychiatry, 2005 Jan; 10(1), S. 40–68, PMID 15263907
B. H. Shirts, V. Nimgaonkar: The genes for schizophrenia: finally a breakthrough? In: Curr Psychiatry Rep., 2004 Aug; 6(4), S. 303–312, PMID 15260947
S. Mah u. a.: Identification of the semaphorin receptor PLXNA2 as a candidate for susceptibility to schizophrenia. In: Mol Psychiatry, (2006) 11, S. 471–478, PMID 16402134.
N. L. Ross, R. Wadekar, A. Lopes, A. Dagnall, J. Close, L. E. Delisi, T. J. Crow: Methylation of two Homo sapiens-specific X-Y homologous genes in Klinefelter’s syndrome (XXY). In: Am J Med Genet B Neuropsychiatr Genet., 2006 Jul 5; 141(5), S. 544–548, PMID 16741946
S. H. Snyder: The dopamine hypothesis of schizophrenia: focus on the dopamine receptor. In: Am J Psychiatry. 1976 Feb; 133(2), S. 197–202, PMID 1251927
A. S. Horn, S. H. Snyder: Chlorpromazine and dopamine: conformational similarities that correlate with the antischizophrenic activity of phenothiazine drugs. In: Proc Natl Acad Sci U S A, 1971 Oct, 68(10), S. 2325–2328, PMID 5289865.
S. H. Snyder: Catecholamines in the brain as mediators of amphetamine psychosis. In: Arch Gen Psychiatry, 1972 Aug; 27(2), S. 169–179, PMID 4339577.
S. H. Snyder: Amphetamine psychosis: a “model” schizophrenia mediated by catecholamines. In: Am J Psychiatry., 1973 Jan, 130(1), S. 61–67, PMID 4345465.
T.J. Crow: Molecular pathology of schizophrenia: more than one disease process? In: Br Med J, 280, 1980, S. 66–68, PMID 6101544.
N. Yu, K. R. Tucker, E. S. Levitan, P. D. Shepard, C. C. Canavier: Implications of cellular models of dopamine neurons for schizophrenia. In: Progress in molecular biology and translational science. Band 123, 2014, S. 53–82, doi:10.1016/B978-0-12-397897-4.00011-5, PMID 24560140, PMC 4351765 (freier Volltext) (Review).
RD Paz, S Tardito, M Atzori, KY. Tseng: Glutamatergic dysfunction in schizophrenia: from basic neuroscience to clinical psychopharmacology. In: Eur Neuropsychopharmacol. 2008 Nov; 18(11): 773-86. Epub 2008 Jul 23. Review, PMID 18650071
EH Wong, JA Kemp, T Priestley, AR Knight, GN Woodruff, LL. Iversen: The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. In: Proc Natl Acad Sci U S A. 1986 Sep; 83(18), S. 7104–7108, PMID 3529096
D.C. Goff, J.T. Coyle: The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. In: American Journal of Psychiatry, 158, 2001, S. 1367–1377, PMID 11532718.
N.J. Penington u. a.: Effects of LSD on Calcium-currents in central 5-HT-containing neurons: 5-HT(1A) receptors may play a role in hallucinogenesis. In: J. Pharmacol. Exp. Ther., 269, 1994, S. 1160–1165, PMID 8014859.
H. Osmond, J. Smythies: Schizophrenia: new approach. In: J. Mental. Sci., 98, 1952, S. 309–322, PMID 14917992.
M Wang u. a.: Schizophrenia, amphetamine-induced sensitized state and acute amphetamine exposure all show a common alteration: increased dopamine D2 receptor dimerization. In: Mol Brain, 2010, 3, S. 25, PMID 20813060
E.C. Johnstone u. a.: Cerebral ventricular size and cognitive impairement in chronic schizophrenia. In: Lancet, 2, 1976, S. 924–926, PMID 62160.
J.D. Van Horn u. a.: Ventricular enlargement in schizophrenia. A meta-analysis of studies of the ventricle: brainratio (VBR). In: Br. J. Psychiatry, 160, 1992, S. 687–697, PMID 1534268.
A. Schmitt u. a.: Aktueller Überblick über strukturelle Magnetresonanztomographie bei Schizophrenie. In: Fortschritte Neurologie Psychiatrie, 2001, 69, S. 105–115, PMID 11305121
RB Zipursky u. a.: Cerebral grey matter volume deficits in first episode psychosis. In: Arch Gen Psychiatry, 1998, 55, S. 540–546, PMID 9633673
C. Arango u. a.: The relationship of clozapin and haloperidol treatment response to prefrontal, hippocampal and caudate brain volumes. In: Neuroreport, 2003, 14, S. 2025–2029, PMID 12900303
PJ. Harrison: Brains at risk of schizophrenia. In: Lancet, 1999, 353, S. 3–4, PMID 10023939
LL Symonds u. a.: Does an increase in sulcal or ventricular fluid predict where brain tissue is lost? In: J Neuroimaging, 1999, 9, S. 201–209, PMID 10540599.
IC Wright u. a.: Meta-analysis of regional brain volumes in schizophrenia. In: Am J Psychiatry, 2000, 157, S. 16–25, PMID 10618008
RW. McCarley u. a.: MRI anatomy of schizophrenia. In: Biol Psychiatry, 1999, 45, S. 1099–1119, PMID 10331102
RP Rajarethinam u. a.: Superior temporal gyrus in schizophrenia: a volumetric MRI study. In: Schizophrenia Research, 2000; 41, S. 303–312, PMID 10708339
P. Falkai u. a.: Disturbed planum temporale asymmetry in schizophrenia. In: Schizophrenia Research, 1995; 14, S. 161–176, PMID 7710997
C. Levitan u. a.: Superior temporal gyral volumes and laterality correlates of auditory hallucinations in schizophrenia. In: Biol Psychiatry, 1999, 46, S. 955–962, PMID 10509178
H Jakob, H. Beckmann: Prenatal developmental disturbances in the limbic allocortex in schizophrenics. In: J Neural Transm, 1986, 65, S. 303–326, PMID 3711886
SE Arnold u. a.: Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions. In: Am J Psychiatry, 1995, 152, S. 738–748, PMID 7726314
K Henke u. a.: Human hippocampus associates information in memory. In: PNAS, 1999; 96, S. 5884–5889, PMID 10318979
DW Zaidel u. a.: Size, shape and orientation of neurons in the left and right hippocampal investigation of normal asymmetries and alterations in schizophrenia. In: Am J Psychiatry, 1997, PMID 9167509
CS Carter u. a.: Functional hypofrontality and working memory dysfunction in schizophrenia. In: Am J Psychiatry, 1998; 155, S. 1285–1287, PMID 9734557
J Schröder u. a.: Cerebral metabolic activity correlates of subsyndroms in chronic schizophrenia. In: Schizophrenia Research, 1996; 19, S. 41–53, PMID 9147495
RM Bilder u. a.: Absence of regional hemispheric volume asymmetries in first episode schizophrenia. In: Am J Psychiatry, 1994; 151, S. 1437–1447, PMID 8092337
TE Schlaepfer u. a.: Decreased regional cortical grey matter volume in schizophrenia. In: Am J Psychiatry, 1994; 151, S. 842–848, PMID 8184992
K Vogeley u. a.: Right frontal hypergyria differentiation in affected and unaffected siblings from families multiply affected with schizophrenia: a morphometric MRI study. In: Am J Psychiatry, 2001; 158, S. 494–496, PMID 11229998
S. Heckers: Neuropathology of Schizophrenia. In: Schizophrenia Bulletin, 1997, 23, S. 403–421, PMID 9327506
MH Chakos u. a.: Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine. In: Lancet, 1995; 345, S. 356–357, PMID 7853978
AM Elkashef u. a.: Basal ganglia pathology in schizophrenia and tardive dyskinesia: an MRI quantitative study. In: Am J Psychiatry, 1995; 151, S. 752–755, PMID 7909412
A Carlsson u. a.: Neurotransmitter aberrations in Schizophrenia. In: Life Sci, 1997; 61, S. 75–94, PMID 9217267
C Gaser u. a.: Detecting structural changes in whole brain based on nonlinear deformations-application to schizophrenia research. In: Neuroimage, 1999; 10, S. 107–113, PMID 10417245
MS Buchsbaum u. a.: PET and MRI of the thalamus in never – medicated patients with schizophrenia. In: Am J Psychiatry, 1996; 153, S. 191–199, PMID 8561198
NC Andreasen u. a.: Defining the phenotype of schizophrenia: cognitive dysmetria and ist neural mechanisms. In: Biol Psychiatry, 1999; 46, S. 908–920, PMID 10509174
G Ende u. a.: Further evidence for altered cerebellar neuronal integrity in schizophrenia. In: Am J Psychiatry, 2005; 162, S. 790–792, PMID 15800155
G. Franzen, D.H. Ingvar: Absence of activation in frontal structures during psychological testing of chronic schizophrenics. In: J Neurol Neurosurg Psychiatry, 38 (1975) S. 1027–1032, PMID 1202164.
D.R. Weinberger u. a.: fMRI applications in schizophrenia research. In: Neuroimage, 4, 1996, S. 118–126, PMID 9345536.
T. Dierks u. a.: Activation of Heschls gyrus during auditory hallucinations. In: Neuron, 22, 1999, S. 615–621, PMID 10197540.
P.K. McGuire u. a.: Increased blood flow in Brocas Area during auditory hallicinations in schizophrenia. In: Lancet, 342, 1993, S. 703–705, PMID 8103821.
B. Bogerts: Neuropathologie der Schizophrenien. In: Fortschr. Neurol. Psychiat, 52, S. 428–437, 1984, PMID 6519627
H. Jakob, H. Beckmann: Prenatal developmental disturbances in the limbic allocortex in schizophrenics. In: J. Neural Transm., 1986, 65, 303, PMID 3711886
P. Falkai u. a.: Entorhinal cortex pre-alpha cell-clusters in schizophrenia: quantitative evidence of a developmental abnormality. In: Biol Psychiatry, 47, 2000, S. 937–943, PMID 10838061
P. Falkai u. a.: No evidence for astrogliosis in brains of schizophrenic patients. A post-mortem study. In: Neuropathol Appl Neurobiol. 25, S. 48–53, 1999, PMID 10194775
T.F. McNeil: Review Article. Obstetric complications in schizophrenic parents. In: Schizophr. Res., 5 (1991) S. 89–101, PMID 1931811.
